Conviction
$ Value
$300K
Shares
15,479
Price
$19
Filed
Nov 18
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ % of holdings >= 50% (+3)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Daughton Michael
Title
Chief Business Officer
CIK
0002089896
Roles
Transaction Details
Transaction Date
2025-11-11
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
22,971
Footnotes
This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $19.30 to $19.51. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price. | This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $19.75 to $20.15. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price. | This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $20.10 to $20.17. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price. | This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $20.10 to $20.22. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price. | This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $20.34 to $20.57. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price.
Filing Info
Daughton Michael's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-08 | TBRG | A | $0 |
| 2025-11-17 | TBRG | ▲ | $358K ★ |
| 2025-11-14 | TBRG | ▲ | $50K |
| 2025-11-13 | TBRG | ▲ | $88K |
| 2025-11-12 | TBRG | ▲ | $203K |
| 2025-11-11 | TBRG | ▲ | $300K |
| 2025-10-15 | TBRG | A | $0 |
Other Insiders at TBRG (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| DYE DAVID A | — | — | 2026-03-16 |
|
Fowler Christopher L
President and CEO
|
— | — | 2026-04-08 |
|
Plessner Kevin
General Counsel
|
— | — | 2026-04-08 |
|
Bassi Vinay
Chief Financial Officer
|
— | — | 2026-04-08 |
|
MacIntyre Vita
Controller
|
— | — | 2026-04-08 |
|
Harse David
General Manager Patient Care
|
— | — | 2026-04-08 |
|
Wilson Merideth
Financial Health GM
|
— | — | 2026-04-08 |
|
Daughton Michael
Chief Business Officer
|
— | — | 2026-04-08 |